Special Campaign 5.0 Preparation Begins Across Department of Pharmaceuticals

Date:

Share post:

 

Special Campaign 5.0 Preparation Begins Across Department of Pharmaceuticals

PharmaGenDRx News Bureau-16th September,2025

3:00 PM IST

The Department of Pharmaceuticals (DoP) under the directory of the Ministry of Chemicals& Fertilizers, has initiated preparatory activities for the upcoming Special Campaign designed for Disposal of Pending Matters (SCDPM) 5.0 effective from from 2nd of October to 31st October, 2025.

The campaign is expected to foster greater transparency, efficiency and public service delivery within the pharmaceutical sector. To be implemented across all DoP departments, PSUs and several institutions, SCDPM 5.0 aims to accelerate clearing backlogs, strengthening record management, and promoting digital practices.

Previous campaigns of SCDPM were successful in disposal and review of files with digitisation of records and cleanliness activities over 11,000 Jan Ausadhi Kendras. Targets for the 2025 campaign will be set by 25th September 2025, ensuring a coordinated effort across all affiliated organizations to achieve measurable outcomes.

By Sharon Bose & Arundhuti Chatterjee

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...